Apriem Advisors’s ResMed RMD Stock Holding History

Apriem Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.49M	Sell	28,906 -1,697	-6%	-$423K	0.62%	35
2025 Q4	$7.37M	Sell	30,603 -549	-2%	-$140K	0.68%	34
2025 Q3	$8.53M	Sell	31,152 -2,891	-8%	-$790K	0.81%	30
2025 Q2	$8.78M	Sell	34,043 -2,957	-8%	-$705K	0.93%	26
2025 Q1	$8.28M	Sell	37,000 -12,381	-25%	-$2.89M	0.97%	28
2024 Q4	$11.3M	Sell	49,381 -16,214	-25%	-$3.9M	1.29%	23
2024 Q3	$16M	Sell	65,595 -3,777	-5%	-$844K	1.87%	14
2024 Q2	$13.3M	Sell	69,372 -486	-0.7%	-$98.6K	1.63%	16
2024 Q1	$13.8M	Buy	69,858 +5,029	+8%	+$921K	1.74%	16
2023 Q4	$11.2M	Buy	64,829 +2,118	+3%	+$325K	1.49%	21
2023 Q3	$9.27M	Buy	+62,711	New	+$11.3M	1.36%	24

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apriem Advisors's RMD Position: Q1 2026 in Review

Apriem Advisors reduced its ResMed (RMD) stake by 5.5% in Q1 2026, selling an estimated $423K and leaving 28,906 shares worth $6.49M. The position accounts for 0.62% of the portfolio, ranked #35.

Apriem Advisors first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. The position peaked at $16M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Apriem Advisors held 28,906 shares of ResMed worth $6.49M as of Q1 2026.
Apriem Advisors sold 1,697 ResMed shares in Q1 2026, an estimated $423K.
ResMed made up 0.62% of Apriem Advisors's portfolio in Q1 2026, its #35 holding.
Apriem Advisors first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
Apriem Advisors's ResMed position peaked at $16M in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Apriem Advisors's 13F filing for Q1 2026, filed 15 May 2026.